JPMorgan Upgrades Oracle to Overweight as Q3 Beat Extends Stock's Rebound

The Upgrade Wave

JPMorgan's Mark Murphy upgraded Oracle from neutral to overweight with a $210 price target on March 11, the most notable call in a wave of analyst reactions to the Q3 print. Deutsche Bank maintained buy with a $300 target, Wells Fargo held overweight at $280, and Goldman Sachs reiterated buy at $228.

The JPMorgan upgrade matters because it was a genuine flip — Murphy had been neutral on Oracle through the stock's 54% drawdown from its September 2025 peak of $327. The Q3 results, particularly the 84% OCI growth acceleration, appear to have resolved his concerns about whether Oracle's massive capex cycle would generate returns. With 34 analysts covering the stock, consensus now sits at a moderate buy with a $274 average target, implying over 60% upside from current levels.

Why $553 Billion in RPO Changes the Risk Profile

The number that keeps coming up in analyst notes is remaining performance obligations: $553 billion, up 325% year-over-year and $29 billion higher sequentially. That figure represents roughly eight years of current revenue run-rate locked in under contract.

What makes the RPO structurally interesting is the funding mechanism. Oracle disclosed that most of the increase came from large-scale AI contracts where customers either prepay for GPU procurement or supply GPUs directly to Oracle. This means Oracle is building out data center capacity without absorbing the full capital risk — the $50 billion in FY2026 capex is substantially de-risked by contracted commitments rather than speculative build-ahead.

Oracle raised $30 billion in February through investment-grade bonds and mandatory convertible preferred stock, with the offering oversubscribed. The debt load is real — long-term obligations now exceed $100 billion — but the contracted revenue backing it gives Oracle a different risk profile than a company building on spec.

Recovery From a Deep Drawdown

Context matters for sizing this move. Oracle shares fell roughly 54% from their September 2025 peak of $327 to about $149 heading into the earnings print. The selloff reflected skepticism about Oracle's ability to convert aggressive AI infrastructure spending into sustainable returns, compounded by pressure on high-multiple tech names from elevated rates.

The Q3 results attack the bear case head-on: revenue growth accelerated to 22%, the best in over 15 years at that growth rate on both revenue and EPS simultaneously. Management raised FY2027 revenue guidance to $90 billion, $3.4 billion above Street consensus. OCI's 84% growth represents an acceleration from 68% last quarter — the trajectory is steepening, not flattening.

At $170, Oracle is still roughly half its all-time high. The 13% move is a sentiment reset backed by real numbers, not a full recovery. Whether the stock re-rates toward the $274 analyst consensus or the $100 billion-plus debt load caps the bounce is the open question heading into Q4.

Trading on Hyperliquid

Trade ORCL on Hyperliquid with up to 10x leverage.